{"id":"lactobacillus-ls","safety":{"commonSideEffects":[{"rate":null,"effect":"Gastrointestinal disturbances (bloating, gas, mild diarrhea)"},{"rate":null,"effect":"Abdominal discomfort"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"anthropic-haiku","explanation":"This live biotherapeutic product works by colonizing the gastrointestinal tract, producing beneficial metabolites, and promoting the growth of commensal bacteria while inhibiting pathogenic organisms. It strengthens the intestinal epithelial barrier through tight junction protein expression and stimulates local and systemic immune responses via pattern recognition receptors on intestinal immune cells.","oneSentence":"Lactobacillus LS is a probiotic strain that modulates the gut microbiota and enhances intestinal barrier function and immune response.","_ai_confidence":"low"},"_scrapedAt":"2026-03-28T01:18:16.849Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Gastrointestinal disorders (specific indication in Phase 3 trial not publicly detailed)"}]},"trialDetails":[{"nctId":"NCT07461233","phase":"NA","title":"Modulation of Gut Microbiota Composition and Gut Permeability Profiles by Multispecies Synbiotic Supplementation in Hemodialysis Patients","status":"NOT_YET_RECRUITING","sponsor":"Tungs' Taichung Metroharbour Hospital","startDate":"2026-04-01","conditions":"Symbiotic, Uremic Toxins, Gut -Microbiota","enrollment":30},{"nctId":"NCT07443280","phase":"NA","title":"Alterations of Gut Derived Uremic Toxins and Microbiome Metabolites by Multispecies Synbiotic","status":"NOT_YET_RECRUITING","sponsor":"Tungs' Taichung Metroharbour Hospital","startDate":"2026-04-01","conditions":"Symbiotic, Uremic Toxins, Gut -Microbiota","enrollment":30},{"nctId":"NCT06936137","phase":"PHASE3","title":": EFFECT OF PROBIOTIC SUPPLEMENTATION ON ATYPICAL ANTIPSYCHOTIC INDUCED WEIGHT GAIN IN PATIENTS ATTENDING PSYCHIATRIC CLINICS AT AINSHAMS UNIVERSITY HOSPITALS (A RANDOMIZED CONTROLLED TRIAL)","status":"RECRUITING","sponsor":"Ain Shams University","startDate":"2025-04-20","conditions":"Antipsychotic Induced Weight Gain","enrollment":180},{"nctId":"NCT06074094","phase":"PHASE4","title":"Probiotic Supplementation IN NAFLD Patients","status":"COMPLETED","sponsor":"Ain Shams University","startDate":"2021-09-12","conditions":"NAFLD","enrollment":50}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":146,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_3","status":"active","brandName":"lactobacillus LS","genericName":"lactobacillus LS","companyName":"Ain Shams University","companyId":"ain-shams-university","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Lactobacillus LS is a probiotic strain that modulates the gut microbiota and enhances intestinal barrier function and immune response. Used for Gastrointestinal disorders (specific indication in Phase 3 trial not publicly detailed).","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}